Splice-altering genetic variants are found in individuals with infantile cardiomyopathy, but the consequences are unclear. A study now shows that aberrant splicing of only one exon in the AARS2 gene can cause devastating heart development defects, phenocopying patient congenital cardiomyopathy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Homsy, J. et al. Science 350, 1262–1266 (2015).
Awaya, T. et al. J. Hum. Genet. https://doi.org/10.1038/s10038-025-01424-z (2025).
Jang, M. Y. et al. Circ. Genom. Precis. Med. 16, 224–231 (2023).
Lu, Y. W. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-026-00798-3 (2026).
Berget, S. M. et al. Proc. Natl Acad. Sci. USA 74, 3171–3175 (1977).
Chow, L. T. et al. Cell 12, 1–8 (1977).
Rohner, E. et al. Nat. Biotechnol. 40, 1586–1600 (2022).
Wang, E. T. et al. Nature 456, 470–476 (2008).
Gerstberger, S. et al. Adv. Exp. Med. Biol. 825, 1–55 (2014).
Verma, S. K. et al. Curr. Top. Dev. Biol. 156, 51–119 (2024).
Sommerville, E. W. et al. Hum. Mol. Genet. 28, 258–268 (2019).
Szpisjak, L. et al. J. Hum. Genet. 62, 329–333 (2017).
MacGrogan, D. et al. Nat. Rev. Cardiol. 15, 685–704 (2018).
Tien, P. C. et al. Oncogene 42, 2521–2535 (2023).
Ji, X. et al. Mol. Cell. Biol. 41, e0066820 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
DeLancey, R.L., Verma, S.K. & Kuyumcu-Martinez, M.N. How RNA splicing decisions shape and break the developing heart. Nat Cardiovasc Res 5, 284–285 (2026). https://doi.org/10.1038/s44161-026-00801-x
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s44161-026-00801-x